A citation-based method for searching scientific literature

Írisz Szabó, Viktória É Varga, Szabolcs Dvorácskó, Attila E Farkas, Tímea Körmöczi, Róbert Berkecz, Szilvia Kecskés, Ákos Menyhárt, Rita Frank, Dóra Hantosi, Nicholas V Cozzi, Ede Frecska, Csaba Tömböly, István A Krizbai, Ferenc Bari, Eszter Farkas. Neuropharmacology 2021
Times Cited: 12







List of co-cited articles
242 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.
Dominique Fontanilla, Molly Johannessen, Abdol R Hajipour, Nicholas V Cozzi, Meyer B Jackson, Arnold E Ruoho. Science 2009
355
75

Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
283
66

N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats.
Sándor Nardai, Marcell László, Attila Szabó, Alán Alpár, János Hanics, Péter Zahola, Béla Merkely, Ede Frecska, Zoltán Nagy. Exp Neurol 2020
27
58



Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.
Lindsay P Cameron, Charlie J Benson, Brian C DeFelice, Oliver Fiehn, David E Olson. ACS Chem Neurosci 2019
58
58

Psychedelics.
David E Nichols. Pharmacol Rev 2016
500
50

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo.
Jose A Morales-Garcia, Javier Calleja-Conde, Jose A Lopez-Moreno, Sandra Alonso-Gil, Marina Sanz-SanCristobal, Jordi Riba, Ana Perez-Castillo. Transl Psychiatry 2020
31
50

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.
Fernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias, Katia C Andrade, Morgana M Novaes, Jessica A Pessoa, Sergio A Mota-Rolim, Flávia L Osório, Rafael Sanches, Rafael G Dos Santos,[...]. Psychol Med 2019
233
41


Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.
Veronica Francardo, Francesco Bez, Tadeusz Wieloch, Hans Nissbrandt, Karsten Ruscher, M Angela Cenci. Brain 2014
146
41

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
Javier González-Maeso, Noelia V Weisstaub, Mingming Zhou, Pokman Chan, Lidija Ivic, Rosalind Ang, Alena Lira, Maria Bradley-Moore, Yongchao Ge, Qiang Zhou,[...]. Neuron 2007
483
41

Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.
Lindsay P Cameron, Charlie J Benson, Lee E Dunlap, David E Olson. ACS Chem Neurosci 2018
63
41

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.
Ede Frecska, Attila Szabo, Michael J Winkelman, Luis E Luna, Dennis J McKenna. J Neural Transm (Vienna) 2013
51
41

The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects.
David B Yaden, Roland R Griffiths. ACS Pharmacol Transl Sci 2020
71
33

Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases.
Jia Jia, Jian Cheng, Cheng Wang, Xuechu Zhen. Front Cell Neurosci 2018
35
33



Psychedelics and the human receptorome.
Thomas S Ray. PLoS One 2010
121
33


Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.
Briony J Catlow, Shijie Song, Daniel A Paredes, Cheryl L Kirstein, Juan Sanchez-Ramos. Exp Brain Res 2013
108
33

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.
Rafael G Dos Santos, Flávia L Osório, José Alexandre S Crippa, Jordi Riba, Antônio W Zuardi, Jaime E C Hallak. Ther Adv Psychopharmacol 2016
123
33

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial.
Raíssa Nóbrega de Almeida, Ana Cecília de Menezes Galvão, Flávia Santos da Silva, Erick Allan Dos Santos Silva, Fernanda Palhano-Fontes, João Paulo Maia-de-Oliveira, Lobão-Soares Barros de Araújo, Bruno Lobão-Soares, Nicole Leite Galvão-Coelho. Front Psychol 2019
61
33

A non-hallucinogenic psychedelic analogue with therapeutic potential.
Lindsay P Cameron, Robert J Tombari, Ju Lu, Alexander J Pell, Zefan Q Hurley, Yann Ehinger, Maxemiliano V Vargas, Matthew N McCarroll, Jack C Taylor, Douglas Myers-Turnbull,[...]. Nature 2021
73
33

Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).
Lindsay P Cameron, David E Olson. ACS Chem Neurosci 2018
41
33

Hallucinogens.
David E Nichols. Pharmacol Ther 2004
711
33

Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.
Calvin Ly, Alexandra C Greb, Maxemiliano V Vargas, Whitney C Duim, Ana Cristina G Grodzki, Pamela J Lein, David E Olson. ACS Pharmacol Transl Sci 2020
24
33

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.
Ling-Xiao Shao, Clara Liao, Ian Gregg, Pasha A Davoudian, Neil K Savalia, Kristina Delagarza, Alex C Kwan. Neuron 2021
58
33

A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus.
Rafael Vitor Lima da Cruz, Thiago C Moulin, Lyvia Lintzmaier Petiz, Richardson N Leão. Front Mol Neurosci 2018
26
33

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report.
Flávia de L Osório, Rafael F Sanches, Ligia R Macedo, Rafael G dos Santos, João P Maia-de-Oliveira, Lauro Wichert-Ana, Draulio B de Araujo, Jordi Riba, José A Crippa, Jaime E Hallak. Braz J Psychiatry 2015
221
33

Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
Rafael G Dos Santos, Marta Valle, José Carlos Bouso, Josep F Nomdedéu, José Rodríguez-Espinosa, Ethan H McIlhenny, Steven A Barker, Manel J Barbanoj, Jordi Riba. J Clin Psychopharmacol 2011
70
33


Neuropharmacology of N,N-dimethyltryptamine.
Theresa M Carbonaro, Michael B Gatch. Brain Res Bull 2016
65
33

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
583
25

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.
Kim Pc Kuypers, Livia Ng, David Erritzoe, Gitte M Knudsen, Charles D Nichols, David E Nichols, Luca Pani, Anaïs Soula, David Nutt. J Psychopharmacol 2019
63
25

Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases.
Daniel A Ryskamp, Svetlana Korban, Vladimir Zhemkov, Nina Kraskovskaya, Ilya Bezprozvanny. Front Neurosci 2019
72
25

Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.
Gabrielle I Agin-Liebes, Tara Malone, Matthew M Yalch, Sarah E Mennenga, K Linnae Ponté, Jeffrey Guss, Anthony P Bossis, Jim Grigsby, Stacy Fischer, Stephen Ross. J Psychopharmacol 2020
84
25

Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
Rafael G Dos Santos, José Carlos Bouso, Miguel Ángel Alcázar-Córcoles, Jaime E C Hallak. Expert Rev Clin Pharmacol 2018
77
25

Serotonin 5-HT₂ receptor activation prevents allergic asthma in a mouse model.
Felix Nau, Justin Miller, Jordy Saravia, Terry Ahlert, Bangning Yu, Kyle I Happel, Stephania A Cormier, Charles D Nichols. Am J Physiol Lung Cell Mol Physiol 2015
42
25

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.
Erich Studerus, Michael Kometer, Felix Hasler, Franz X Vollenweider. J Psychopharmacol 2011
197
25

Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin.
Oskar Hougaard Jefsen, Betina Elfving, Gregers Wegener, Heidi Kaastrup Müller. J Psychopharmacol 2021
19
25

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Stephen Ross, Anthony Bossis, Jeffrey Guss, Gabrielle Agin-Liebes, Tara Malone, Barry Cohen, Sarah E Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb,[...]. J Psychopharmacol 2016
484
25

Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency.
Bangning Yu, Jaime Becnel, Mourad Zerfaoui, Rasika Rohatgi, A Hamid Boulares, Charles D Nichols. J Pharmacol Exp Ther 2008
106
25

Trial of Psilocybin versus Escitalopram for Depression.
Robin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, Michelle Baker-Jones, Ashleigh Murphy-Beiner, Roberta Murphy, Jonny Martell, Allan Blemings, David Erritzoe, David J Nutt. N Engl J Med 2021
211
25

Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Jonathan Hamill, Jaime Hallak, Serdar M Dursun, Glen Baker. Curr Neuropharmacol 2019
43
25

Assessment of addiction severity among ritual users of ayahuasca.
Josep Maria Fábregas, Débora González, Sabela Fondevila, Marta Cutchet, Xavier Fernández, Paulo César Ribeiro Barbosa, Miguel Ángel Alcázar-Córcoles, Manel J Barbanoj, Jordi Riba, José Carlos Bouso. Drug Alcohol Depend 2010
107
25

Psychedelics as anti-inflammatory agents.
Thomas W Flanagan, Charles D Nichols. Int Rev Psychiatry 2018
57
25


Psychedelics as Medicines: An Emerging New Paradigm.
D E Nichols, M W Johnson, C D Nichols. Clin Pharmacol Ther 2017
121
25

The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice.
Maninder Malik, Claudia Rangel-Barajas, Nathalie Sumien, Chang Su, Meharvan Singh, Zhenglan Chen, Ren-Qi Huang, Johann Meunier, Tangui Maurice, Robert H Mach,[...]. Br J Pharmacol 2015
29
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.